Scientific Center for Anti-infectious Drugs, Kazakhstan
Quick facts
Marketed products
- FS-1 · Other
Phase 2 pipeline
- Efesovir · Other
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: